Background & Aims In 2017, the World Health Organization (WHO) designated
clarithromycin-resistant Helicobacter pylori a high priority for antibiotic research and …

Background Knowledge of global clarithromycin (CLA)-resistant rates of Helicobacter pylori
(H. pylori) is crucial for decision of the most appropriate eradication therapies with good …

Helicobacter pylori (H. pylori) infection is one of the most common bacterial infections,
affecting almost half of the world's population. It is associated with peptic ulcer disease …

Aim To evaluate the efficacy and tolerability of tetracycline vs. high-dose amoxicillin in
bismuth-based quadruple therapy for Helicobacter pylori (H. pylori) eradication. Methods …

Background Helicobacter pylori is an important pathogen of human gastric mucosa.
Antibiotic resistance, especially resistance to clarithromycin is a major factor for treatment …

Background The high prevalence of clarithromycin-resistant strains of Helicobacter pylori is
a main challenge for the successful treatment of gastrointestinal infections. Point mutations …

Background H elicobacter pylori (H. pylori) eradication has always been a concern. In our
pervious study, 14‐day hybrid regimen showed ideal results. Based on these findings, we …

Abstract Background Antimicrobial resistance of Helicobacter pylori can result in eradication
failure. Metadata on the antimicrobial resistance of H pylori in Iran could help to formulate H …

Helicobacter pylori is a common gastric bacterial pathogen implicated in the pathogenesis of
many digestive tract disorders. H. pylori infection prevalence has been reported alarmingly …

Background: Resistance to clarithromycin in HELICOBACTER PYLORI has become one of
the most important reasons for failure of antibiotic eradication therapies. This resistance is …